ProBioGen AG

Berlin, Germany Founded: 1994 • Age: 32 yrs Acquired By Minipharm Pharmaceuticals.
Contract development and manufacturing organization focussed on therapeutic proteinsantibodies, viral vaccines and biosimilars
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About ProBioGen AG

ProBioGen AG is a company based in Berlin (Germany) founded in 1994 was acquired by Minipharm Pharmaceuticals. in June 2010. ProBioGen AG has completed 1 acquisition, including Minipharm Pharmaceuticals. ProBioGen AG offers products and services including Cell Line Development, GMP Manufacturing, Process Development, and Analytics and Bioassays. ProBioGen AG operates in a competitive market with competitors including Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex, among others.

  • Headquarter Berlin, Germany
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Probiogen Ag
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ProBioGen AG

ProBioGen AG offers a comprehensive portfolio of products and services, including Cell Line Development, GMP Manufacturing, Process Development, and Analytics and Bioassays.

Product name locked
Category locked
Primary

Develops cell lines for biopharmaceutical production and optimization.

Product name locked
Category locked
Locked

Produces biopharmaceuticals under GMP standards for clinical use.

Product name locked
Category locked
Locked

Designs and optimizes processes for biopharmaceutical and viral production.

Product name locked
Category locked
Locked

Performs testing and analysis for biopharmaceutical quality assurance.

People of ProBioGen AG

Headcount 200-500
Employee Profiles 33
Employee Profiles
People
Anika Bauer
Associate Scientist
People
Doreen Uebe
Associate Scientist
People
Lina Hanisch
Biotechnologist Vaccine Strategies
People
Ingo Jordan
Vice President Vaccine Strategies

Unlock access to complete

Funding Insights of ProBioGen AG

Investors in ProBioGen AG

ProBioGen AG has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Merus and Minipharm Pharmaceuticals.

All
Institutional
Investor Description Founded Year Domain Location
Antibody-based drugs for cancer treatment are developed using bispecific engineering.
Locked Locked Locked
Pharma and biopharma products are manufactured by Minipharm.
Locked Locked Locked
Premium access

Investor details for ProBioGen AG

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ProBioGen AG

ProBioGen AG has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Minipharm Pharmaceuticals..

Investments
Premium access

Investment portfolio details for ProBioGen AG

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Pharma and biopharma products are manufactured by Minipharm.
Locked Locked 1958 Locked
Premium access

Complete acquisition details for ProBioGen AG

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - ProBioGen AG

Premium access

Detailed financials for ProBioGen AG

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Probiogen Ag Comparisons

ProBioGen AG Primary company
Description
Contract development and manufacturing organization focussed...
Location
Berlin, Germany
Founded Year
1994
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ProBioGen AG

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ProBioGen AG

ProBioGen AG operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Mammalian cell culture biologics are developed through contract research services.
Locked Locked Locked
Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs
Locked Locked Locked
Contract manufacturing solutions for biologics are provided to Asian companies.
Locked Locked Locked
Drug substance development, analytical, and compliance services are provided.
Locked Locked Locked
Biologics development and GMP manufacturing services are offered.
Premium access

Detailed competitors of ProBioGen AG

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Probiogen Ag

Premium access

Complete news archive for ProBioGen AG

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ProBioGen AG

ProBioGen AG was founded in 1994 and raised its 1st funding round 24 years after it was founded.

ProBioGen AG is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

ProBioGen AG was founded in 1994 in Berlin, Germany, as a contract development and manufacturing organization in the biopharmaceutical sector. Cell line engineering, upstream and downstream process development, and GMP manufacturing are provided for therapeutic proteins, antibodies, viral vaccines, and biosimilars. Services encompass customized packages from initial cell line development through to full production programs, supported by physicochemical analyses and activity assays.

ProBioGen AG's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.

ProBioGen AG offers Cell Line Development, GMP Manufacturing, Process Development, and Analytics and Bioassays.

ProBioGen AG has made 1 acquisition, including Minipharm Pharmaceuticals.

ProBioGen AG has 2 investors. Key investors include Merus, and Minipharm Pharmaceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available